Cargando…

Detection of indoleamine 2,3-dioxygenase 1-expressing cells in canine normal and tumor tissues

Cancer immunotherapy is a novel cancer treatment for canine tumors. Indoleamine 2,3-dioxygenase 1 (IDO1) is overexpressed in some human tumors and inhibits antitumor immunity. In this study, we comprehensively evaluated expression pattern of IDO1 and the nature of IDO1-expressing cells in canine nor...

Descripción completa

Detalles Bibliográficos
Autores principales:	IKEDA, Namiko, KATO, Daiki, TSUBOI, Masaya, YOSHITAKE, Ryohei, ETO, Shotaro, YOSHIMOTO, Sho, SHINADA, Masahiro, KAMOTO, Satoshi, HASHIMOTO, Yuko, TAKAHASHI, Yousuke, CHAMBERS, James, UCHIDA, Kazuyuki, NISHIMURA, Ryohei, NAKAGAWA, Takayuki
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Japanese Society of Veterinary Science 2021
Materias:	Surgery
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8762412/ https://www.ncbi.nlm.nih.gov/pubmed/34690223 http://dx.doi.org/10.1292/jvms.21-0217

Ejemplares similares

Immunohistochemical evaluation of HER2 expression in canine thyroid carcinoma
por: Yoshimoto, Sho, et al.
Publicado: (2019)

Overexpression of human epidermal growth factor receptor 2 in canine primary lung cancer
por: YOSHIMOTO, Sho, et al.
Publicado: (2020)

Anti-tumor effects of the histone deacetylase inhibitor vorinostat on canine urothelial carcinoma cells
por: Eto, Shotaro, et al.
Publicado: (2019)

Detection of human epidermal growth factor receptor 2 overexpression in canine anal sac gland carcinoma
por: YOSHIMOTO, Sho, et al.
Publicado: (2019)

PDPN Is Expressed in Various Types of Canine Tumors and Its Silencing Induces Apoptosis and Cell Cycle Arrest in Canine Malignant Melanoma
por: Shinada, Masahiro, et al.
Publicado: (2020)

Phase I/II Clinical Trial of the Anti-Podoplanin Monoclonal Antibody Therapy in Dogs with Malignant Melanoma
por: Kamoto, Satoshi, et al.
Publicado: (2020)

Expression of podoplanin in various types of feline tumor tissues
por: KAMOTO, Satoshi, et al.
Publicado: (2021)

Aberrant expression of the COX2/PGE(2) axis is induced by activation of the RAF/MEK/ERK pathway in BRAF(V595E) canine urothelial carcinoma
por: Yoshitake, Ryohei, et al.
Publicado: (2020)

The impact of damage-associated molecules released from canine tumor cells on gene expression in macrophages
por: Eto, Shotaro, et al.
Publicado: (2021)

Author Correction: Aberrant expression of the COX2/PGE(2) axis is induced by activation of the RAF/MEK/ERK pathway in BRAF(V595E) canine urothelial carcinoma
por: Yoshitake, Ryohei, et al.
Publicado: (2020)

Podoplanin promotes cell proliferation, survival, and migration of canine non-tonsillar squamous cell carcinoma
por: SHINADA, Masahiro, et al.
Publicado: (2023)

Retrospective study of canine cutaneous tumors in Japan, 2008–2017
por: KOK, Mun Keong, et al.
Publicado: (2019)

ErbB2 copy number gain is associated with adverse outcome in canine mammary carcinoma
por: SAKAI, Kosei, et al.
Publicado: (2021)

Anti-CCR4 treatment depletes regulatory T cells and leads to clinical activity in a canine model of advanced prostate cancer
por: Maeda, Shingo, et al.
Publicado: (2022)

Localization of Indoleamine 2,3-Dioxygenase-1 and Indoleamine 2,3-Dioxygenase-2 at the Human Maternal-Fetal Interface
por: Kudo, Yoshiki, et al.
Publicado: (2020)

Urinary lipid production profile in canine patients with splenic mass
por: KIDA, Taiki, et al.
Publicado: (2022)

Comprehensive profiling of lipid metabolites in urine of canine patients with liver mass
por: KIDA, Taiki, et al.
Publicado: (2022)

Editorial: Targeting Indoleamine 2,3-dioxygenases and Tryptophan Dioxygenase for Cancer Immunotherapy
por: Brochez, Lieve, et al.
Publicado: (2021)

Targeting Indoleamine Dioxygenase and Tryptophan Dioxygenase in Cancer Immunotherapy: Clinical Progress and Challenges
por: Peng, Xuerun, et al.
Publicado: (2022)

Sarcomatoid mesothelioma of tunica vaginalis testis in the right scrotum of a dog
por: SON, Nguyen V., et al.
Publicado: (2018)

Targeting the indoleamine 2,3-dioxygenase pathway in cancer
por: Moon, Yong Wha, et al.
Publicado: (2015)

The Mechanism of Substrate Inhibition in Human Indoleamine 2,3-Dioxygenase
por: Efimov, Igor, et al.
Publicado: (2012)

Indoleamine-2,3-dioxygenase activity induces neutrophil apoptosis
por: Van der Sluijs, K, et al.
Publicado: (2011)

Indoleamine-2,3-dioxygenase activity in experimental human endotoxemia
por: Padberg, Jan-Sören, et al.
Publicado: (2012)

The Role of Indoleamine 2, 3-Dioxygenase in Immune Suppression and Autoimmunity
por: Mbongue, Jacques C., et al.
Publicado: (2015)

The role of placental indoleamine 2,3-dioxygenase in human pregnancy
por: Kudo, Yoshiki
Publicado: (2013)

The inhibition of indoleamine 2, 3-dioxygenase 1 by connexin 43
por: Lin, Han-Chen, et al.
Publicado: (2017)

Advances in indoleamine 2,3-dioxygenase 1 medicinal chemistry
por: Coletti, Alice, et al.
Publicado: (2017)

Indoleamine 2,3-Dioxygenase and Tolerance: Where Are We Now?
por: Mellor, Andrew L., et al.
Publicado: (2017)

Role of indoleamine 2,3-dioxygenase in pathology of the gastrointestinal tract
por: Acovic, Aleksandar, et al.
Publicado: (2018)

Role of indoleamine 2,3-dioxygenase in testicular immune-privilege
por: Gualdoni, Gisela S., et al.
Publicado: (2019)

Indoleamine dioxygenase and tryptophan dioxygenase activities are regulated through control of cell heme allocation by nitric oxide
por: Biswas, Pranjal, et al.
Publicado: (2023)

Indoleamine 2, 3‐dioxygenase 1 promoter hypomethylation is associated with poor prognosis in patients with esophageal cancer
por: Kiyozumi, Yuki, et al.
Publicado: (2019)

Comparison of the effect of growth factors on chondrogenesis of canine mesenchymal stem cells
por: ENDO, Kentaro, et al.
Publicado: (2019)

Indoleamine 2,3-Dioxygenase in Human Hematopoietic Stem Cell Transplantation
por: Jürgens, Birgit, et al.
Publicado: (2010)

The paradoxical patterns of expression of indoleamine 2,3-dioxygenase in colon cancer
por: Gao, Yan-Fang, et al.
Publicado: (2009)

The Role of Indoleamine 2,3-Dioxygenase in Diethylnitrosamine-Induced Liver Carcinogenesis
por: Shibata, Yuhei, et al.
Publicado: (2016)

Nanomedicine and cancer immunotherapy: focus on indoleamine 2,3-dioxygenase inhibitors
por: Zulfiqar, Bilal, et al.
Publicado: (2017)

The Role of Indoleamine-2,3-Dioxygenase in Cancer Development, Diagnostics, and Therapy
por: Hornyák, Lilla, et al.
Publicado: (2018)

Hypoxia enhances indoleamine 2,3-dioxygenase production in dendritic cells
por: Song, Xiang, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_igm7gdcst6tgbp00afq5pah8km